Criteria for evaluating operator competency for performing coronary interventions should be expanded beyond procedure volume and include an evaluation of risk-adjusted outcomes, periodic case reviews of patient selection and other factors, according to a new report from the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions.


Preliminary results from the ADVISE (Adenosine Vasodilator Independent Stenosis Evaluation) II trial confirm prior retrospective publications and demonstrate the clinical usefulness of an iFR/fractional flow reserve (FFR) hybrid approach to simplify lesion assessment and to save the use of hyperemic drugs in a significant number of patients. It was also announced that this hybrid iFR/FFR strategy, along with intravascular ultrasound (IVUS) guidance, will be used in the multi-center SYNTAX2 trial in Europe starting later this year.

Agfa began its global release of ICISTM View 3.0, the medical images and results viewer for the comprehensive ICIS enterprise imaging solution. The ICIS patient imaging data platform is a fundamental part of the company’s global e-health strategy. Building on its leadership in enterprise imaging management and web-enabled technology, Agfa HealthCare’s ICIS View 3.0 allows clinicians, specialists, and all other stakeholders to access all patient imaging data from any PACS or VNA, using a single viewer, to support continuity and productivity of patient care. This cost- effective solution leverages the hospital’s existing investment in technology, and provides access to the most current and relevant patient imaging data directly from the source.

St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN IV Renal Denervation Study, the first U.S. trial using the EnligHTN Multi-Electrode Renal Denervation System to treat patients with drug-resistant high blood pressure.


Abbott has announced publication of positive outcomes from two European post-approval studies of the catheter-based MitraClip therapy for the treatment of mitral regurgitation (MR). Results from ACCESS-EU, a European prospective study that enrolled 567 patients at 14 sites, have been published in the Journal of the American College of Cardiology. In addition, findings of the investigator-sponsored German TRAnscatheter Mitral Valve Interventions (TRAMI) registry, which enrolled 1,064 patients at 20 German sites, were recently published in EuroIntervention.

Tryton Medical Inc. announced that the Nordic-Baltic Bifurcation Study Group will investigate the Tryton Side Branch Stent. The trial is a prospective, controlled, randomized, multicenter clinical study examining the role of final kissing balloon inflations in patient outcomes. A total of 150 patients will receive the Tryton Side Branch Stent with a drug-eluting stent, with evaluation by intravascular optical coherence tomography (OCT) imaging technology.

Mirada Medical collaborators has presented new positron emission tomography/magnetic resonance imaging (PET/MRI) research. The software supports both the hardware hybrid scanners and provides validated deformable registration for software based PET/CT (computed tomorgraphy)/MRI.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now